Halozyme Drug Patent Portfolio
Halozyme owns 1 orange book drug protected by 1 US patent Given below is the list of Halozyme's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7767429 | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof | 23 Sep, 2027 | Active |
Latest Legal Activities on Halozyme's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Halozyme.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 01 Dec, 2021 | US7767429 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 08 Jan, 2018 | US7767429 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 04 Apr, 2011 | US7767429 (Litigated) |
|
Correspondence Address Change
Critical
| 30 Mar, 2011 | US7767429 (Litigated) |
| Sequence Moved to Public Database | 09 Aug, 2010 | US7767429 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 03 Aug, 2010 | US7767429 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 03 Aug, 2010 | US7767429 (Litigated) |
|
Issue Notification Mailed
Critical
| 14 Jul, 2010 | US7767429 (Litigated) |
| Printer Rush- No mailing | 25 Jun, 2010 | US7767429 (Litigated) |
|
Pubs Case Remand to TC
Critical
| 22 Jun, 2010 | US7767429 (Litigated) |
| Dispatch to FDC | 07 Jun, 2010 | US7767429 (Litigated) |
| Mail-Record a Petition Decision of Granted for Patent Term Adjustment after Allowance | 01 Jun, 2010 | US7767429 (Litigated) |
| Record a Petition Decision of Granted for Patent Term Adjustment after Allowance | 01 Jun, 2010 | US7767429 (Litigated) |
| Adjustment of PTA Calculation by PTO | 31 May, 2010 | US7767429 (Litigated) |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 11 Mar, 2010 | US7767429 (Litigated) |
Halozyme's Family Patents
Halozyme Drug List
Given below is the complete list of Halozyme's drugs and the patents protecting them.
1. Hylenex Recombinant
Hylenex Recombinant is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7767429 | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
23 Sep, 2027
(1 year, 8 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hylenex Recombinant's drug page